Literature DB >> 12153817

The outcome of anorexia nervosa in the 20th century.

Hans-Christoph Steinhausen1.   

Abstract

OBJECTIVE: The present review addresses the outcome of anorexia nervosa and whether it changed over the second half of the 20th century.
METHOD: A total of 119 study series covering 5,590 patients suffering from anorexia nervosa that were published in the English and German literature were analyzed with regard to mortality, global outcome, and other psychiatric disorders at follow-up.
RESULTS: There were large variations in the outcome parameters across studies. Mortality estimated on the basis of both crude and standardized rates was significantly high. Among the surviving patients, less than one-half recovered on average, whereas one-third improved, and 20% remained chronically ill. The normalization of the core symptoms, involving weight, menstruation, and eating behaviors, was slightly better when each symptom was analyzed in isolation. The presence of other psychiatric disorders at follow-up was very common. Longer duration of follow-up and, less strongly, younger age at onset of illness were associated with better outcome. There was no convincing evidence that the outcome of anorexia nervosa improved over the second half of the last century. Several prognostic features were isolated, but there is conflicting evidence. Most clearly, vomiting, bulimia, and purgative abuse, chronicity of illness, and obsessive-compulsive personality symptoms are unfavorable prognostic features.
CONCLUSIONS: Anorexia nervosa did not lose its relatively poor prognosis in the 20th century. Advances in etiology and treatment may improve the course of patients with anorexia nervosa in the future.

Entities:  

Mesh:

Year:  2002        PMID: 12153817     DOI: 10.1176/appi.ajp.159.8.1284

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  287 in total

1.  The longitudinal BMI pattern and body composition of patients with anorexia nervosa who require urgent hospitalization: A case control study.

Authors:  Keisuke Kawai; Sakino Yamashita; Takeharu Yamanaka; Motoharu Gondo; Chihiro Morita; Takehiro Nozaki; Shu Takakura; Tomokazu Hata; Yu Yamada; Sunao Matsubayashi; Masato Takii; Chiharu Kubo; Nobuyuki Sudo
Journal:  Biopsychosoc Med       Date:  2011-12-05

2.  Management of anorexia nervosa revisited.

Authors:  Janice Russell
Journal:  BMJ       Date:  2004-02-28

3.  Somatic problems and self-injurious behaviour 18 years after teenage-onset anorexia nervosa.

Authors:  Elisabet Wentz; I Carina Gillberg; Henrik Anckarsäter; Christopher Gillberg; Maria Råstam
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-04-07       Impact factor: 4.785

4.  School counselors' knowledge of eating disorders.

Authors:  J L Harshbarger; C R Ahlers-Schmidt; M Atif; E Allred; M Carroll; R Hauser
Journal:  Eat Weight Disord       Date:  2011-06       Impact factor: 4.652

5.  Borderline personality, self-harm behavior, and treatment outcome among eating disorders.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2005-11

6.  Pharmacological treatment of eating disorders.

Authors:  Kiranmai Gorla; Maju Mathews
Journal:  Psychiatry (Edgmont)       Date:  2005-06

Review 7.  Neuromodulation for the treatment of eating disorders and obesity.

Authors:  Darrin J Lee; Gavin J B Elias; Andres M Lozano
Journal:  Ther Adv Psychopharmacol       Date:  2017-12-08

Review 8.  Reconceptualizing anorexia nervosa.

Authors:  Cynthia M Bulik; Rachael Flatt; Afrouz Abbaspour; Ian Carroll
Journal:  Psychiatry Clin Neurosci       Date:  2019-07-01       Impact factor: 5.188

9.  The significance of bradycardia in anorexia nervosa.

Authors:  Malka Yahalom; Marcelo Spitz; Ludmila Sandler; Nawaf Heno; Nathan Roguin; Yoav Turgeman
Journal:  Int J Angiol       Date:  2013-06

10.  Reasons for non-participation in follow-up research on eating disorders.

Authors:  T Björk; D Clinton; C Norring
Journal:  Eat Weight Disord       Date:  2006-09       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.